Clinical Trial Update: Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CMC-544 in B-cell non-Hodgkin's lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Lymphoma B-cell

Drugs mentioned

• CMC-544

Snippet

Sponsor: Pfizer | Conditions: Lymphoma, B-Cell | Phase 1 | Status: COMPLETED | Results posted: 2018-10-26